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Intracellular traffic between compartments of the secretory and endocytic pathways is
mediated by vesicle-based carriers. The proteomes of carriers destined for many organelles
are ill-defined because the vesicular intermediates are transient, low-abundance and difficult
to purify. Here, we combine vesicle relocalisation with organelle proteomics and Bayesian
analysis to define the content of different endosome-derived vesicles destined for the trans-
Golgi network (TGN). The golgin coiled-coil proteins golgin-97 and GCC88, shown previously
to capture endosome-derived vesicles at the TGN, were individually relocalised to mito-
chondria and the content of the subsequently re-routed vesicles was determined by organelle
proteomics. Our findings reveal 45 integral and 51 peripheral membrane proteins re-routed
by golgin-97, evidence for a distinct class of vesicles shared by golgin-97 and GCC88, and
various cargoes specific to individual golgins. These results illustrate a general strategy for
analysing intracellular sub-proteomes by combining acute cellular re-wiring with high-
resolution spatial proteomics.
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A major goal of cell biology is to define the logic of vesiculartraffic between organelles of the secretory and endocyticpathways. These trafficking pathways control organelle
identity, abundance and function, as well as the precise comple-
ment of proteins on the cell surface. The content of vesicle car-
riers contains information of both the cargoes that define each
trafficking route and the specificity cues that determine their
destination. Hence, deconvolution of intracellular trafficking
would be greatly aided by knowing the complete content of
vesicles that connect the various cellular compartments. Many
vesicles have a short lifetime, are found in low amounts and are
difficult to purify. Thus, other than synaptic vesicles, which can
be purified in large amounts1, the proteomes of transport vesicles
that connect different organelles are incompletely defined.
Accurate membrane traffic depends on tethers at destination
organelles that selectively capture incoming transport vesicles2,3.
The golgins, a large and ancient family of ubiquitously expressed
long coiled-coil proteins of the Golgi apparatus, function as
tethers that contribute to the specificity of membrane traffic by
selectively capturing transport vesicles prior to SNARE-mediated
fusion4–7. The specific vesicles captured by the golgins are likely
to represent a major proportion of the overall vesicles destined for
the Golgi. However, the content of these vesicles remains poorly
defined and so they are ideal targets for the development of
strategies of vesicle purification.
Each Golgi compartment is decorated with a distinct set of
golgins that are anchored to the membrane via their C termini,
with golgin-97, golgin-245, GCC88 and GCC185 found at the
trans-Golgi in mammalian cells7–9. Mutation of these trans-Golgi
golgins results in only mild phenotypes, suggesting redundancies
between them that make it challenging to investigate their func-
tions10. This problem was overcome by an in vivo assay for golgin
tethering that tested whether the golgins are sufficient, rather
than necessary, to function as vesicle tethers11. Golgins were
relocated to an ectopic site by swapping their C termini with a
mitochondrial transmembrane domain (golgin-mito). This was
found to be sufficient to redirect specific transport vesicles to the
mitochondria and maintain them in a permanently tethered state
(Fig. 1a). Using this assay, golgin-97-mito, golgin-245-mito and
GCC88-mito specifically capture endosome-to-Golgi vesicles,
with the mitochondrial TMD itself causing no detectable vesicle
accumulation or mitochondrial stress11,12. Golgin-97 and golgin-
245 share a conserved vesicle-binding motif at their N-termini
which they use to capture the same pool of vesicles13. This motif
binds directly to TBC1D23, a member of a family of Rab GTPase-
activating proteins, and TBC1D23 bridges golgin-97 and golgin-
245 to endosome-to-Golgi vesicles (Fig. 1a)14. TBC1D23 also
binds to WDR11/FAM91A1/C17orf75, a protein complex of
unknown function, although the precise role of this interaction
remains unclear14–16.
Many open questions regarding endosome-to-Golgi traffic
remain. Multiple sorting nexins, as well as retromer and the
clathrin adaptor AP-1 have been reported to act in this retrograde
route but the number of distinct carriers and the precise role of
the known trafficking components is uncertain17–19. Examining
the retrograde transport vesicles could provide insight into these
questions, but such vesicles are challenging to study as they are
small and generally short-lived as they are rapidly consumed by
fusion to the trans-Golgi. Ectopic capture of vesicles by golgins
relocated to mitochondria provides a means to investigate their
composition as the lack of relevant SNAREs on mitochondria
means that the vesicles accumulate in a tethered state. Golgin-97
and golgin-245 have been reported to bind AP-1-derived vesicles
through TBC1D23 and, possibly, the WDR11 complex; however,
it is evident that AP-1 independent vesicles are also captured by
these golgins15. In addition, the vesicle-associated specificity
factors that target transport vesicles to GCC88 are unknown, and
the physiological roles that distinguish GCC88 from golgin-97
and golgin-245 are still poorly defined. To elucidate these ques-
tions, we set out to determine the content of the vesicles that are
captured by golgin-97 and GCC88.
Applying in vivo proximity biotinylation to golgins relocated
to mitochondria has been used successfully to identify direct
binding partners and some vesicle cargo (Fig. 1a)14. However,
its limited biotinylation range prevents this approach from
determining the entire content of vesicles. Moreover, it is
skewed against the identification of small proteins and proteins
that have few exposed lysines to biotinylate, such as the short
cytoplasmic tails of the transmembrane proteins that comprise
the cargo of transport vesicles. In addition, mitochondrial
purification by cell fractionation and immune-purification each
come with their own caveats. Thus far, no method of cell
fractionation achieves complete separation of organelles. Nor
do they take into account the change in size and density of the
mitochondria due to vesicle capture across treatments. In
contrast, organelle proteomics methods such as the Localisation
of Organelle Proteins by Isotope Tagging after Differential
ultraCentrifugation (LOPIT-DC) method combines cell frac-
tionation with quantitative mass spectrometry and multivariate
data analysis to allow simultaneous characterisation of multiple
sub-cellular compartments, without the requirement for total
purification of compartments of interest (Fig. 1b, d)20–24. In
this work, we opted to combine the mitochondrial relocation
assay with LOPIT-DC proteomics to determine which vesicle
cargo, adaptors and accessory proteins are redirected to mito-
chondria by golgin-97-mito and GCC88-mito. We find known
cargo and many further transmembrane and peripheral mem-
brane proteins to be associated with the vesicles captured by
golgin-97, and find evidence for a distinct class of vesicle that
can also be captured by GCC88. Together, we show that the
combination of relocalisation of sub-cellular compartments and
high-resolution spatial proteomics can be used as a general
strategy to define intracellular sub-proteomes.
Results and discussion
LOPIT-DC on mitochondrial relocated golgin-97 and GCC88.
An overview of the LOPIT-DC work flow we used is shown in
Fig. 1b, d. LOPIT-DC was applied to Flp-In 293 cells expressing
golgin-97-mito, GCC88-mito or a mitochondrial TMD (mito) as
a control (Fig. 1c). The profiles of approximately 6000 proteins
present across three independent replicates for each treatment
were obtained using multiplexing with conventional tandem mass
spectrometry (MS2) (Supplementary Data 1). A prediction of the
sub-cellular localisation for each protein was then made by
matching individual profiles to profiles of known organelle
markers using supervised machine learning with support vector
machines (SVM), as well as using Bayesian statistical modelling
through the T-Augmented Gaussian Mixture model (TAGM)
method (Fig. 1d)25. The latter takes into account the uncertainty
that arises when classifying proteins that reside in multiple
locations, or unknown functional compartments and also those
that dynamically move within the cell, and so provides a richer
overall analysis of spatial proteomics data25–28.
The performance of tandem mass tag (TMT)-based quantifica-
tion by MS2 can be affected by interference from contaminant
peptides with similar properties to the target peptide, but if this
does occur it has to be addressed by an additional round of ion
selection and fragmentation in synchronous precursor selection
mass spectrometry (SPS-MS3)29. Our LOPIT-DC data analysed
by MS2 showed effective separation of organelles with good
resolution (Supplementary Fig. 1a, b), even though the overall
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resolution of SPS-MS3 is somewhat better23. Since our application
of LOPIT-DC was not aimed at resolving subtle differences in the
overall profiles of different organelles, but instead aimed at
detecting clear changes in the profile of putative vesicle proteins
between samples, our requirements were satisfied by using the
simpler and less expensive MS2 approach.
To identify proteins that translocate to mitochondria as a result
of the expression of mitochondrial golgins, we initially leveraged
the spatial information of our LOPIT-DC data by applying an
independent pre-filtering step. Thus, proteins predicted by
TAGM to localise to the mitochondria or nucleus in the mito
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are likely to be resident mitochondrial and nuclear proteins that
are not relevant to our biological question. Discarding them made
it easier to discern proteins that shift toward a mitochondrial
profile in golgin-mito cell lines (Supplementary Fig. 1c).
We next analysed our data by quantifying general changes in
protein profiles between golgin-mito cells and control cells using
a Bayesian non-parametric two-sample test (Bayes Factor). To
quantify protein profiles that shift towards a mitochondrial
profile we computed a mitochondrial ratio (MitoRatio - see
Methods). As expected, our strongest hits when comparing our
LOPIT-DC of golgin-97-mito to the mito control were golgin-97
itself and TBC1D23 (Fig. 1e). Likewise, GCC88 was the strongest
hit when comparing GCC88-mito to the mito control (Fig. 1f).
Golgin-97-mito had more high scoring proteins than GCC88-
mito, suggesting that golgin-97 has a greater overall ability to
accumulate vesicles. This is consistent with our previous
observations, and was further corroborated through quantitation
of immunofluorescence microscopy (Fig. 1g and Supplementary
Fig. 2a)13.
We next set a threshold for protein relocation to the
mitochondria based on confirmed experimental observations
(Fig. 1e, f). The major criterion was that this threshold should
have all subunits of the WDR11 complex (WDR11, FAM91A1
and C17orf75), as hits when comparing mito versus golgin-97-
mito, but not when comparing mito versus GCC88-mito (Fig. 1a,
e, f)14. Application of this threshold also predicted ATG9A and
Furin, normally resident in Golgi membranes and endosomes, as
cargo of vesicles captured by golgin-97-mito (Fig. 1e)30,31. We
verified this by immunofluorescence (Fig. 1h, i), demonstrating
that the vesicles that recycle them to the Golgi can be captured by
golgin-97 but not GCC88 or GCC185. Together, these data
demonstrate the effectiveness of our Bayesian analysis of the
LOPIT-DC data.
Cargo specific to golgin-97. Proteins trafficking along the ret-
rograde route to the Golgi are in a constant state of flux as
they are continuously recycled throughout the endosomal
network17,32. Consistent with this phenomenon, we observed a
strong enrichment for proteins of the endosomal network
amongst those affected by golgin-97-mito. This includes pro-
teins classified by multiple localisation databases and by our
LOPIT-DC analysis as being localised to the endosome, lyso-
some, Golgi or plasma membrane (PM), or present on vesicles
(Supplementary Data 2). Of these, a total of 45 transmembrane
proteins were robustly affected, including IGF2R (CI-MPR),
M6PR (CD-MPR) and TGN46, which are known cargo of
vesicles captured by golgin-97 and golgin-245 (Fig. 2a, b)13. In
addition, we also detected 5 SNAREs involved in the fusion of
endosome-to-Golgi vesicles to the trans-Golgi. The majority of
these transmembrane proteins had profiles similar to endo-
somes in our control, and then shifted to a more mitochondrial
profile as a result of golgin-97-mito in our LOPIT-DC analysis
(Fig. 2c, d). These shifts are partial, which is consistent with
vesicles accumulating over the time course of the experiment
with some cargo proteins still in transit, or in vesicles that have
escaped capture by the mitochondrial golgins. Based on these
results, we define these transmembrane proteins as cargo of
vesicles captured by golgin-97.
Retrograde trafficking to the trans-Golgi is typically challen-
ging to interrogate because of the range of machinery and
pathways that have been proposed to be responsible for recycling
specific cargo in specific vesicles17,19,33. Of these different
pathways, the content of AP-1 derived vesicles is the best
resolved34–36. We detected 16 protein that are known AP-1 cargo
as being clearly affected by golgin-97-mito, consistent with
previous reports of AP-1 vesicles binding to golgin-97 and golgin-
24515. Of these, TVP23 is a poorly characterised TGN protein
that has been implicated in endosome-to-Golgi trafficking in
yeast, and secretion from the TGN in plants37–39. We found that
TVP23B is specifically relocated to the mitochondria by golgin-
97-mito and not GCC88-mito (Fig. 2e, f and Supplementary
Fig. 2b). Furin is also a cargo of AP-1 that showed similar results
(Fig. 1i). Together, this supports a conclusion that GCC88 has
minimal ability to capture clathrin/AP-1-derived vesicles.
A significant complicating factor in the study of retrograde
trafficking is that many cargo proteins contain multiple sorting
motifs that allow adaptors from numerous sorting pathways to
bind to them. This redundancy has made it challenging to
conclusively determine the necessity of some of these pathways.
In addition to AP-1 cargo, we also identified 29 other cargo that
are likely to be in transport vesicles derived from other sorting
pathways that are captured by golgin-97 and, by inference,
golgin-245 (Fig. 2b). These proteins are thus candidates that
may be exploited in the future to further elucidate these
pathways. An example is the autophagy protein ATG9A and its
partner SERINC1, which are known to be sorted by AP-4
adaptors into vesicles secreted from the TGN to the periphery
Fig. 1 LOPIT-DC on mitochondrial relocated golgin-97 and GCC88. a Applying proximity biotinylation to mitochondrially relocated golgin-97 identifies its
interaction with TBC1D23 and the WDR11 complex on endosome-to-Golgi vesicles. b Overview of the LOPIT-DC work flow. Cells are gently lysed and
fractionated by differential ultracentrifugation. The peptides of each fraction are then labelled with 11-plex TMT, pre-fractionated through high-pH reversed
phase UPLC and then analysed by MS2 or SPS-MS3. This gives the profiles of the proteome, which are then analysed as in d. Image is adapted from the
LOPIT-DC methods paper23, under a Creative Commons Attribution 4.0 International License [http://creativecommons.org/licenses/by/4.0/].
c Immunoblot of proteins from Flp-In 293 cells stably expressing the doxycycline-inducible mito, golgin-97-mito and GCC88-mito with 1 μg ml−1
doxycycline for 48 h, representative of two independent experimental replicates. d Principle component analysis (PCA) projections for the LOPIT-DC
showing organelle markers before classification, after SVM classification and after TAGM classification. e, f Results of MitoRatio versus Bayes Factor
analysis comparing mito control to golgin-97-mito and GCC88-mito. Thresholds are based on experimentally confirmed hits (see text) (log2(MitoRatio) ≥
0.40, loge(Bayes Factor) ≥ 14.0). Mito versus golgin-97-mito: 140 proteins in addition to golgin-97 were within threshold out of 5914 analysed proteins
(3591 after pre-filtering), all 140 listed in Supplementary Data 2. Mito versus GCC88-mito: 16 proteins in addition to GCC88 were within threshold out of
5532 analysed proteins (3585 proteins after pre-filtering), all 16 listed in Supplementary Data 2. g Quantification of confocal micrographs of Flp-In 293 cells
as used in LOPIT-DC (Supplementary Fig. 2a) measuring the ratio of the mean intensity of TGN46 at the mitochondria over its intensity at the Golgi
(MitoRatio). Boxplots are of MitoRatios of all cells quantified across 3 independent experiments (n≥ 114), and show the median, the first and third quartiles
(Q1 and Q3), minimum (Q1-1.5 × interquartile range (IQR)), and maximum (Q3+ 1.5 × IQR). p-values are of two-sample two-sided t-tests comparing the
overall mean MitoRatio of each replicate. Data are provided as a Source Data file. h, i Confocal micrographs of HeLa cells expressing the indicated golgin-
mito construct (HA) stained for endogenous ATG9A or exogenous Furin-GFP, all micrographs representative of three independent experimental replicates.
Scale bars, 10 μm.
ARTICLE NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-020-19840-4
4 NATURE COMMUNICATIONS |         (2020) 11:5987 | https://doi.org/10.1038/s41467-020-19840-4 | www.nature.com/naturecommunications
of the cell40. Importantly, our analysis did not detect AP-4 or its
accessory proteins, RUSC1 and RUSC2. This strongly suggests
that ATG9A and SERINC1 are on retrograde vesicles derived
from an as yet undefined sorting pathway. ATG9A is an
important regulator of autophagosome formation and SERINC
proteins have recently been identified as HIV restriction
factors41,42. Their relocation to mitochondria by golgin-97-
mito could provide a valuable assay for future studies on the
role of these proteins.
Adaptor proteins and accessory factors of vesicles specific to
golgin-97. The discovery of TBC1D23 and the WDR11 complex
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vesicles captured by golgin-97-mito14. This suggests that per-
ipheral membrane proteins relocated to the mitochondria by
golgin-97-mito could be adaptor proteins and accessory factors
involved in the tethering process. The localisations of 51 per-
ipheral membrane proteins of the endosomal network were
affected by golgin-97-mito (Fig. 3a, b), including VPS45, an SM
(Sec1p / Munc18) protein involved in the fusion of endosome-to-
Golgi vesicles with the TGN. We also found an enrichment for
adaptor proteins and accessory factors from multiple endosomal
sorting pathways, including AP-1 adaptors (AP1G1, AP1S2,
AP1AR, AP1M1 and AP1S1) and accessory proteins (CLINT1,
SYNRG, PI4K2B and Rab9), but not their associated clathrin
coat34,36,43,44. We also found proteins involved in retromer-
dependent transport (SNX3, SNX4, VPS35, VPS26, VPS29),
along with SNX-BAR proteins potentially involved in retromer-
independent transport (SNX1, SNX2, SNX5 and SNX6)45,46.
Many peripheral membrane proteins are localised to multiple
compartments in the cell, making them difficult to classify by
spatial proteomics (Fig. 3c). However, we clearly observed that
golgin-97-mito induced a movement of these proteins to a more
mitochondrial profile (Fig. 3c-f). As with TBC1D23, we would
expect that the more mitochondrial these peripheral membrane
proteins become, the greater likelihood of them binding directly
to golgin-9714. SPRYD7 is an example of a protein of unknown
function that localises endogenously to vesicles and fits this cri-
terion (Figs. 1e, 3a)47.
An alternative explanation for our enrichment of adaptor
proteins could be that golgin-97-mito recruits endosomes or TGN
-derived vesicles to the mitochondria48. Lysosomal hydrolases are
key markers of anterograde transport that traffic through the
TGN and endosomes enroute to the lysosome. We did not
observe any noticeable shift of lysosomal hydrolases to the
mitochondria by golgin-97-mito in our analysis (Supplementary
Fig. 3). Likewise, endosomal markers EEA1 and Rab5 did not
show a detectable shift to mitochondrial fractions (Supplemen-
tary Data 2). We also performed correlative light and electron
tomography (CLEM) on cells expressing golgin-97-mito and
found an accumulation of spherical and oval structures
surrounding the mitochondria that were roughly 30 to 80 nm
in diameter, which correlates well with the predicted size of
transport vesicles (Fig. 4a-e and Supplementary Movie 1)49.
Together, these data support a model in which golgin-97-mito
captures retrograde transport carriers formed by AP-1, SNX3,
SNX4 and SNX-BAR proteins. It also suggests that a subset of
adaptor proteins remain on endosome-to-Golgi carriers as they
voyage to the TGN.
Redirection of peroxisomes by mitochondrial golgins. The
ectopic tethering of large numbers of vesicles to golgin-coated
mitochondria is likely to have some indirect effects on the rest of
the cell. This is evident by the change in morphology of the
mitochondria by electron microscopy as they become
increasingly zippered together by vesicles11. We detected a total
of 43 proteins affected by golgin-97-mito that are not asso-
ciated with the endosomal network (Supplementary Fig. 4a, b).
Of these, 34 were peroxisomal proteins which were shifted to a
more mitochondrial profile by both golgin-97-mito and GCC88-
mito (Supplementary Fig. 4c). The extent of this shift was more
pronounced with the former, which correlated with its stronger
overall ability to capture vesicles (Fig. 1g). Consistent with this,
peroxisomes were found adjacent to mitochondria in the pre-
sence of golgin-97-mito, but not in the presence of the BioID-
mito control, when examined by immunofluorescence (Supple-
mentary Fig. 4d). The reasons for this are unclear, but peroxi-
somes and mitochondria have a co-dependent relationship in
the β-oxidation of fatty acids and the detoxification of
reactive oxygen species50. Moreover, evidence of peroxisome-
mitochondria contact sites, particularly at mitochondria-ER
junctions, have been reported in yeast and mammalian cells51–
53. Our LOPIT-DC data may provide further evidence of this co-
dependence, but irrespective of the reasons it demonstrates the
overall power and sensitivity of the LOPIT-DC coupled to
Bayesian analysis approach.
GCC88 and golgin-97 share a distinct pool of TMEM87A and
TGN46 enriched vesicles. Of 16 total proteins most strongly
affected by GCC88-mito, the largest shifts in localisation were for
TMEM87A and TGN46 (Fig. 1f). TMEM87A is a member of the
enigmatic LU7TM family of GPCR-related proteins that has been
implicated in endosome-to-Golgi retrograde transport and that
localise to the TGN54–56. TGN46 and TMEM87A have nearly
identical profiles in the control cells, and both were clearly shifted
toward the mitochondria by GCC88-mito (Fig. 5a-c). As with
TGN46, TMEM87A was also relocated to the mitochondria by
golgin-97-mito (Figs. 5b, c, 2b). Furthermore, TMEM87A-RFP
localised to spherical structures of roughly 50 nm diameter teth-
ered adjacent to the mitochondria by golgin-97-mito ana-
lysed with CLEM (Figs. 4b–d, 5d)49. As described above, some
cargo proteins relocated by golgin-97 are not captured by GCC88
and so TMEM87A must be enriched in a distinct class of retro-
grade transport vesicles.
The retrograde trafficking of IGF2R and M6PR from endo-
somes to the Golgi involves clathrin/AP-1, retromer-dependent
and independent pathways34,45,57,58. However, our LOPIT-DC of
GCC88-mito had no detectable effect on either of these cargo
(Fig. 5b), suggesting that the distinct pool of TMEM87A and
TGN46 enriched vesicles that GCC88 captures is not dependent
on these particular retrograde pathways. GCC88-mito has been
reported previously to capture IGF2R and M6PR enriched
vesicles when expressed by transient transfection13,58. It is likely
that the lower, stable, expression levels of GCC88-mito used in
our LOPIT-DC experiments allowed us to only detect a distinct
pool of vesicles.
Fig. 2 Golgi/endosome membrane proteins of vesicles specific to golgin-97. a MitoRatio versus Bayes Factor analysis of mito versus golgin-97-mito
showing all hits (blue) that are both localised to the Golgi/endosomal network and are also transmembrane proteins. Axes start at the cut offs shown in
Fig. 1e, ie log2(MitoRatio) = 0.40, loge(Bayes Factor) =14.0). b All hits shown in a ordered from left column to right column based on descending
MitoRatio scores. Classification of their localisation and sorting pathway is based on multiple localisation databases and previous publications. c PCA
projections for the LOPIT-DC of mito versus golgin-97-mito showing SVM classifications and all hits from a, b. d TMT reporter ion distributions of proteins
across fractions for each replicate for mito versus golgin-97-mito showing the profiles of known mitochondrial markers (Mitochondria) and all hits from a,
b (Vesicle Cargo). e Confocal micrographs of HeLa cells expressing the indicated golgin-mito construct (HA) stained for endogenous TVP23B (cargo) and
GM130 (marker of cis-Golgi). All micrographs representative of three independent experimental replicates, scale bars 10 μm. f Quantification of
micrographs of Flp-In 293 cells used in LOPIT-DC (Supplementary Fig. 2b) showing the ratio of TVP23B intensity at the mitochondria to intensity at the
Golgi (MitoRatio). Boxplots show MitoRatios from three independent replicates, each of n≥ 209 cells, as for Fig. 1g. P-values are of two-sample two-sided
t-tests comparing the overall mean of each replicate. Data are provided as a Source Data file.
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TGN46 has previously been shown to depend on golgin-97,
golgin-245 and TBC1D23 for Golgi accumulation14. To extend
this study to GCC88, we generated Δgcc88mutants using CRISPR-
Cas9 (Fig. 6a). When TGN46 is missorted from endosomes, it is
diverted to lysosomes and degraded, allowing efficacy of its sorting
to be quantified by both immunofluorescence and blotting59, but
we observed only a mild decrease in TGN46 levels in the Δgcc88
mutant by blotting (Fig. 6a). Similarly, the localisation of
TMEM87A to the TGN became more diffuse in Δtbc1d23 mutants
and in Δgolgin-97 / Δgolgin-245 mutants by immunofluorescence,
whereas the Δgcc88 mutant did not have a significant effect
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Fig. 3 Adaptor proteins and accessory factors of vesicles specific to golgin-97. a MitoRatio versus Bayes Factor analysis of mito versus golgin-97-mito
showing all hits (blue) that are both localised to the endosomal network and are also soluble proteins (axes truncated as in Fig. 2a). b All hits shown in a
ordered from left column to right column based on descending MitoRatio scores. Classification of their localisation and sorting pathway is based on
multiple localisation databases and literature. c PCA projections for the LOPIT-DC of mito versus golgin-97-mito showing SVM classifications and the
indicated proteins coloured based on the sorting pathway they have been proposed to belong to a, b. d–f. TMT reporter ion distributions of proteins across
fractions for each replicate for mito versus golgin-97-mito showing the profiles of known mitochondrial markers (mitochondria) and all hits from
a, b that have been reported belong to the indicated sorting pathways.
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and golgin-245 also recruit TMEM87A and TGN46 enriched
vesicles via TBC1D23, and are more efficient at capturing these
vesicles than GCC88. Nonetheless GCC88 is still able to capture a
set of vesicles that contains TMEM87A and TGN46 but not
abundant retrograde cargo such as the mannose 6-phosphate
receptors. Our results also indicate that GCC88 is redundant with
golgin-97 and golgin-245 in capturing certain pools of vesicles. In
support of this, knockdown of GCC88 in Δgolgin-97 / Δgolgin-245
mutants stopped cell growth (Fig. 6d).
In conclusion, we have illustrated the power of combining
vesicle relocalisation with high-resolution spatial proteomics as
an effective means of characterising the content of intracellular
transport vesicles. Our study provides an extensive list of cargo
proteins that move along these retrograde routes, as well as
peripheral membrane proteins that may act on these carriers,
which will hopefully provide a valuable resource for further
investigation on this important aspect of intracellular membrane
traffic. We have validated four cargo that had not previously been
reported as being captured by mitochondrial golgins (ATG9A,
TVP23B, furin and TMEM87A). Nonetheless, it should be noted
that we applied an empirical cut-off to select a set of high scoring
hits for further analysis and, like any statistical cut-off, it is to
some extent arbitrary. Thus, some of the other hits may not be in
vesicles, and conversely some of those below the cut-off,
especially those close to the boundary, may actually be in vesicles.
However, the full list of data provided in Supplementary Data 2,
and the relative simplicity of the mitochondrial golgin relocation
assay should enable others to readily test the vesicle location of
their proteins of interest. Finally, this approach is not limited to
trafficking vesicles and could be applied to any protein complex
or sub-cellular compartment with resident proteins that can be
relocated to an ectopic site. Thus, we present a general strategy to
define intracellular sub-proteomes within their native cellular
environment.
Methods
Plasmids and antibodies. The golgin-mito plasmids used for transient transfec-
tion were generated from C-terminally truncated golgins that were PCR-amplified
from human GCC88 and golgin-97 cDNA using GCC88_F / GCC88ΔC_R and
G97_F / G97ΔC_R primers (Supplementary Table 1), and cloned into a pcDNA3.1
+ plasmid so as to express the entire golgin without the GRIP domain followed by
an HA epitope tag and the mitochondrial-targeting TMD of monoamine oxidase
(MAO)13. GCC88-mito, golgin-97-mito and Mito were PCR-amplified from these
plasmids with GCC88_F / Mito_R, G97_F / Mito_R and Mito_F / Mito_R, and
cloned into pcDNA5/FRT/TO to generate pMX0269, pMX0267 and pMX0266
used to make stable lines. BioID was PCR-amplified using BioIDC’ F and R primers
and subcloned into pcDNA3.1+ and pcDNA5/FRT/TO plasmids tagged to Mito to
generate BioID-mito used for transient transfection (pJJS112) and to make stable
lines (pJJS128). Furin-GFP (pJJS084) for transient transfection was generated by
PCR-amplification of human Furin CCDS10364.1 cDNA using FurinC’ F and R
primers, and cloned into a pcDNA3.1+ plasmid tagged to EGFP. TMEM87A-RFP
(pJCO003) for transient transfection was generated from PCR-amplification of
TMEM87A from 293 cells using TMEM87AC’ F and R primers, and cloned into a
pcDNA3.1+ plasmid tagged to mRFP. eSpCas9 (Addgene, 71814) and pIRESpuro3
(Clontech) were used to generate CRISPR-Cas9 stable cell lines. eSpCas9 was
digested with BbsI and GCC88cas9, G97cas9, G245cas9, TBC1D23cas9 Top and
Bottom primers were annealed and inserted by oligonucleotide cloning to generate
plasmids used to make Δgolgin-97, Δgcc88, Δgolgin-245, Δtbc1d23 mutant cell
lines14. All primary antibodies used in this study are described in Supplementary
Table 2. Secondary antibodies were Alexa Fluor-conjugated donkey sera against the
relevant species (Thermo Scientific).
Cell culture, transfection, CRISPR knockout cell lines and immuno-
fluorescence. Cell lines HeLa (ATCC) and Flp-In T-REx 293 (Thermo Scientific,
R78007) were cultured in Dulbecco’s modified Eagle’s medium (DMEM; Invitro-
gen) supplemented with 10% foetal calf serum (FCS) and penicillin/streptomycin at
37 °C and 5% CO2. To transduce Flp-In 293 cells with pMX0267, pmX0269,
pMX0266 and pJJS128, cells were grown in 6-well plates to ∼50% confluence and
transfected with 1 μg pOG44 (Flp recombinase vector) and 1 μg pcDNA5/FRT/TO-
based plasmid using 6 μl FuGENE 6 in 200 μl of Opti-MEM. The medium was
replaced after one day, and after two days cells were trypsinised, expanded in
medium containing 100 μg ml−1 hygromycin, and verified by induction of
expression with 1 μg ml−1 doxycycline and immunoblotting for the HA epitope.
Plasmid pJJ269 was used to generate Δgcc88 Hela cells as for the Δtbc1d23 mutant
and Δgolgin-97 / Δgolgin-245 mutant HeLa cells14. All cell lines were tested reg-
ularly to ensure that they were mycoplasma free (MycoAlert, Lonza). For immu-
nofluorescence, cells were transfected with plasmid DNA using FuGENE 6
according to the manufacturer’s instructions (Promega). Cells were fixed with 4%
formaldehyde in PBS and permeabilised in 0.5% (v/v) Triton X-100 in PBS. Cells
were blocked for one hour in PBS containing 20% FCS and 0.25% Tween-20. If this
protocol did not show good Golgi staining for a particular antibody, cells were
permeabilised and blocked in 20% FCS and 0.1% saponin. Primary and secondary
antibodies were applied sequentially in blocking buffer at dilutions given in Sup-
plementary Table 2. For quantitation of immunofluorescence experiments, a cell
mask was defined by over-exposed DAPI. HA and GM130 were used to mark the
mito construct and the Golgi, respectively (NIS-Elements, Nikon). Then the mean
intensity of the cargo channel in the mitochondria mask (excluding the areas that
overlap with the Golgi mask) were divided by the mean intensity of the cargo
channel of the Golgi mask for each quantified cell. The mitochondria and Golgi
mask had a minimum threshold of 18% of the mean labelling of their respective
markers to exclude poorly expressed constructs or out-of-focus Golgi. For quan-
tification of Golgi localisation, the mean intensity of the cargo in the Golgi mask
was divided by the mean intensity of GM130 in the Golgi mask.
Cell viability assay. Δgolgin-97 / Δgolgin-245 HeLa cells were cultured in DMEM
supplemented with 10% foetal calf serum (FCS) at 37 °C and 5% CO2. On day 0, a
6-well plate was seeded with 180,000 cells per well to obtain a confluency of
40–50% the following day. Cells were transfected in triplicate on day 1 and day 5
with 30 pmol siRNA against GCC88 (Dharmacon ON-TARGETplus human GCC1
SMARTpool L-017478-00-005) or control RNAi (Dharmacon ON-TARGETplus
Golgin-97-mito
(~ 350 nm slices through a virtual tomogram)
1 2 3 4


















































































































Fig. 4 Electron tomography of vesicles captured by golgin-97-mito. a CLEM of a Lowicryl-embedded HeLa cell expressing golgin-97-mito and
TMEM87A-RFP throughout a thickness of approximately 350 nm. Mitochondria are large dense structures (pink stars) sandwiching small circular
structures. Images are representative of two independent experiments. Scale bars 100 nm. b–d Boxplots showing quantitation of spherical structures in a
through 3D segmentation using LimeSeg (50 quantified structures over two independent tomograms, data provided in the Source Data file), boxplots as for
Fig. 1g. e 3D projections of indicated quantified structures in b–d, scale in nm. Data are provided as a Source Data file.
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non-targeting pool D-001810-10-05) using 9 µl Lipofectamine RNAiMAX
(Thermo Scientific) in a final volume of 250 µl Opti-MEM media as described in
the manufacturer’s instructions. Starting on day 2, and thereafter every 48 h, cells
were washed twice in EDTA, trypsinised and resuspend in an appropriate volume
of complete media and counted in a Countess II Automated Cell Counter (Thermo
Scientific). Cells were subsequently either re-plated in their entirety (GCC1 RNAi)
or diluted so that they would not overgrow during the course of the experiment
(control RNAi), with a correction factor applied to the cell count to take this
dilution into account.
Immunoblotting. One 75 cm2 flask of cells at ~90% confluence was harvested by
scraping and centrifugation (1000 × g, 5 min), washed twice with ice-cold PBS,
resuspended in 300 to 500 μl lysis buffer (50 mM Tris pH 7.4, 0.1 M NACl, 1 mM
EDTA, 1% Triton X-100, 1 mM PMSF, cOmplete inhibitors) for 30 min on ice,
clarified by centrifugation (10,000 × g, 10 min at 4 °C), and protein concentration
was determined (BCA assay, Thermo Scientific). Lysate concentrations were
normalised, and the lysates were heated in NuPAGE SDS sample buffer containing
10% β-mercaptoethanol at 90 °C for 5 min, run on a gel and transferred to
nitrocellulose. All blots were blocked in 5% (w/v) milk in PBS-T (PBS with 0.1%
(v/v) Tween-20) for 1 h, incubated overnight at 4 °C with primary antibody in the
same blocking solution (Supplementary Table 2), washed three times with PBS-T
for 5 min, incubated with a 1:3000 dilution of species-specific HRP-conjugated
secondary antibody (GE Life Sciences) in 0.1% (w/v) milk in PBS-T for 1 h, washed
five times with PBS, and detected with Immobilon Western HRP substrate
(Merck).
Correlative fluorescence microscopy and electron tomography of resin-
embedded cells. Correlative fluorescence microscopy and electron tomography
(CLEM) of resin-embedded cells used established methods as follows49,60. HeLa
cells were grown on carbon-coated 3 mm sapphire discs (Wohlwend GmbH) in
six-well plates for 24 hours and transfected with 1 μg golgin-97-mito and 1 μg
TMEM87A-RFP using FuGENE 6, and stained with MitoTracker Deep Red. The










































































































d Golgin-97-mito + TMEM87A-RFP
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Fig. 5 GCC88 and golgin-97 share a distinct pool of TMEM87A and TGN46 enriched vesicles. a PCA projections for the LOPIT-DC of mito versus
GCC88-mito showing SVM classifications and the top six hits that are localised to the endosomal network from Fig. 1f. b TMT reporter ion distributions of
proteins across fractions for each replicate for mito, golgin-97-mito and GCC88-mito showing the profiles of known mitochondrial markers (Mitochondria)
and the indicated proteins. c Confocal micrographs of HeLa cells expressing BioID-mito and the indicated golgin-mito constructs (HA) stained for
endogenous TMEM87A (cargo). Micrographs representative of three independent experiments, scale bars 10 μm. d Correlative light and electron
tomography of resin-embedded HeLa cells co-transfected for 24 hours with golgin-97-mito and TMEM87A-RFP (green), and stained with mitotracker
DeepRed (magenta) to label mitochondria. Left: Fluorescence micrograph of a section of a resin-embedded cell. White circles indicate TMEM87A-RFP
signals localised in the electron tomogram. Middle-left: Virtual slice from the electron tomogram acquired at the area indicated with a white square on the
left image—green crosses indicate predicted positions of the TMEM87A-RFP signal centroids shown on the fluorescence image. Tomogram representative
of two independent replicates. Middle: magnified area from white square in the tomogram slice showing vesicles accumulated between two mitochondria,
with two views of a 3D segmentation model of this same area (mitochondria in purple and vesicles in green). Full tomogram and rendering in
Supplementary Movie 1.
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cells were frozen under high pressure using an HPM100 (Leica Microsystems),
freeze-substituted using 0.008% uranyl acetate in acetone and embedded in Low-
icryl HM20 (Polysciences) using an AFS2 (Leica Microsystems). The samples were
sectioned into 350 nm thin sections using a microtome (Leica Microsystems) and a
diamond knife (Diatome). The sections were collected on 200 mesh copper grids
with carbon support (S160, Agar Scientific Ltd). 100 nm TetraSpeck microspheres
(Invitrogen, T7279) diluted 1:200 in PBS pH 8.4 were adsorbed for 5 min to the
sections and used as fiducial markers for correlation. Fluorescence images were
acquired using a Ti2 wide field microscope (Nikon) equipped with a Niji LED light
source (Bluebox Optics), a ×100 oil-immersion TIRF objective (NA= 1.49) and a
Neo sCMOS DC-152Q-C00-Fl camera (Andor). Filters: 49002 ET-GFP (Chroma),
49005 ET-DSRed (Chroma), 49006 ET-Cy5 (Chroma). Electron microscopy was
done using a Tecnai F20 (FEI) operated at 200 kV and a high tilt tomography
holder (Fischione Instruments; Model 2020). Montage images of regions of interest
were acquired on a BM-Orius detector using transmission EM at approximately
130 μm defocus, at a pixel size of 1.1 nm and using the montaging function in
SerialEM v3.8.061. The correlation between the montage images and the fluores-
cence images was achieved by matching the fiducial marker positions in the EM
image and the fluorescence image60,62. Electron tomographic tilt series were
acquired from 60 to −60 degrees with one degree increments, using the Scanning
TEM mode (STEM) on an axial bright field detector, at pixel sizes of 1.1 nm and
2.2 nm. Tomograms were reconstructed using IMOD v4.10.2963. The dataset is
representative of 18 correlated tomograms were acquired from three cells dis-
tributed on two sapphire discs. Circular structures approximately 100 nm adjacent
to mitochondria in tomograms were 3D segmented using the ImageJ plugin
LimeSeg v0.4.464. The average, minimal and maximal radius, along with overall
volume of the 3D segmentations of each structure were then measured. The 3D
segmentation model was made by manual tracing followed by simplification and
smoothening using Amira v20.19.4 (Thermo Scientific) and IMOD v4.10.2963.
LOPIT-DC sample preparation. Organelle proteomics of Flp-In 293 lines
expressing inducible mito-golgins was performed using the LOPIT-DC method23.
Cells from at least eight T175 flasks per treatment were passaged so that they were
approximately 50% confluent after 24 h. After this time, 1 μg ml-1 doxycycline was
added to the medium and incubated for 48 h. The cells were pelleted at 200 × g and
washed thrice in ice-cold PBS, and then weighed to measure cell quantity. A
minimum of 0.7 g of cell pellet were resuspended in 4 ml of ice-cold detergent-free
lysis buffer (LB) (250 mM sucrose, 10 mM HEPES pH 7.5, 2 mM EDTA, 2 mM
magnesium acetate tetrahydrate, cOmplete protease tablet (Roche)) and incubated
on ice for 5 min. The cell suspension was then lysed with a ball bearing homo-
geniser using a 12 μm tungsten carbide ball (Isobiotec) until approximately 90% of
cells were visibly lysed by trypan blue staining. Unlysed cells and insoluble cell
debris were pelleted from the homogenate by centrifugation at 200 × g for 20 min
three times. A nuclei prep (NUC) was then performed on the collected pellet by
resuspending it in 25% OptiPrep (Sigma-Aldrich), underlaying this with 30% and
35% OptiPrep, and then centrifuging this gradient at 10,000 × g for 20 min at 4 °C.
The interface containing the nuclei was carefully collected with a syringe, washed 6
times with LB by pelleting at 22,000 × g for 20 min each, and the final NUC pellet
then frozen. The cell homogenate was then fractionated by differential ultra-
centrifugation through the following sequential spins at 4 °C: P1 pellet, 1000 × g for
20 min; P2 pellet, 3000 × g for 10 min; P3 pellet, 5000 × g for 10 min; P4 pellet,
9000 × g for 15 min; P5 pellet, 12,000 × g for 15 min; P6 pellet, 15,000 × g for 15
min; P7 pellet, 30,000 × g for 20 min; P8 pellet, 79,000 × g for 43 min; P9 pellet,
120,000 × g for 3 h. Each collected pellet was spun again under the same condition
and the final pellet was frozen. The pellets were thawed the next day and both the
NUC and P1 pellet were treated with 250 units of benzonase nuclease (Sigma-
Aldrich, E1014) for 10 min on ice to reduce viscosity. All pellets were then solu-
bilised with approximately 200 μL of membrane solubilisation buffer (MSB) (50
mM HEPES pH 8.5, 0.2% SDS, 8M Urea) and sonicated for 3 times 30 s pulses on
highest setting while avoiding overheating above room temperature. Solubilised
fractions were then clarified by centrifugation at 20,000 × g for 5 min. The protein
concentration of each fraction was measured using the Pierce BCA Protein Assay
Kit, and a 50 μg per 100 μL aliquot of each fraction was then reduced by incubating
with 10 mM DTT for 2 h at room temperature, and alkylated by incubating with
25 mM iodoacetamide (Sigma-Aldrich, I6125) for 2 h at room temperature. The
samples were then diluted with 1 volumes of water, and precipitated in at least 6
volumes of pre-chilled acetone overnight at −20 °C. The precipitated pellets were
decanted and allowed to air dry for 3 min, resuspended in 100 μL of 50 mM HEPES
pH 8.5 buffer, vortexed, sonicated and then trypsinised overnight according to the
manufacturer’s instructions (Promega, V5111). The subsequent peptide fractions
were labelled with TMT10plex and TMT11plex (Thermo Scientific), multiplexed
according to the manufacturer’s instructions, and then lyophilised. The samples
were then resuspended in 0.8 mL 0.1% trifluoroacetic acid (Thermo Scientific,
85183) and desalted with Sep-Pak tC18 (Waters, WAT036820), and then lyophi-
lised. The samples were resuspended in 100 μL of 95% Buffer A (20 mM ammo-
nium formate, pH 10), 5% Buffer B (20 mM ammonium formate pH 10, 80%
acetonitrile). High-pH reverse phase chromatography was performed using a












































































































































Fig. 6 GCC88 and golgin-97/golgin-245 have redundant roles that together support cell viability. a Immunoblot of proteins from wild-type and mutant
HeLa cells probed with antibodies against the indicated proteins, blot representative of two independent experiments. b Confocal micrographs of wild-type
and mutant HeLa cells stained for endogenous TMEM87A (cargo), GM130 (marker of cis-Golgi) and DAPI. Micrographs representative of three
independent experiments, scale bars, 10 μm (5 μm in zoom). c Quantification of b measuring the ratio of the intensity of TMEM87A at the Golgi over that
of GM130. Boxplots are of data from three independent replicates, n≥ 300 per replicate, as for Fig. 1g. P-values are of two-sided two-sample t-tests
comparing the means of ratios from the three replicates for each cell type. d Effect of knockdown of GCC88 on growth of Δgolgin-97 / Δgolgin-245 double
knockout HeLa cells - three replicates per time point (error bars show mean and SD). Data are provided as a Source Data file.
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Waters Acquity UPLC with gradients of Buffer A and Buffer B through Acquity
BEH C18 column and trap column (Waters, 186002353 and 186003975), and
collected into a series of pre-fractions. Only pre-fractions found within a Gaussian
distribution of peptides determined by the UV detector were kept. The first and
middle pre-fractions were concatenated, and this pattern was repeated with every
subsequent pre-fraction until 18 total concatenated pre-fractions remained and
were lyophilised.
Mass spectrometry. Liquid chromatography was performed on the concatenated
RP-UPLC pre-fractionated TMT-labelled peptides on a fully automated Ultimate
3000 RSLC nano System (Thermo Scientific) fitted with a 100 μm × 2 cm Pep-
Map100 C18 nano trap column (Aclaim PepMap, Thermo Scientific) and a 75 μm
× 25 cm, nanoEase C18 T3 column (Waters). Samples were separated using a
binary gradient consisting of buffer A (2% MeCN, 0.1% formic acid) and buffer B
(80% MeCN, 0.1% formic acid) with a flow rate of 300 nL/min. The HPLC system
was coupled to a Q Exactive Plus mass spectrometer (Thermo Scientific) equipped
with a nanospray ion source. The mass spectrometer was operated in standard
data-dependent mode, with MS full-scan at 380–1600m/z range, and a resolution
of 70,000. This was followed by MS2 acquisitions of the 15 most intense ions with a
resolution of 35000 and NCE of 33%. MS target values of 3e6 and MS2 target
values of 1e5 were used. Isolation window of precursor was set at 0.7 Da, and
dynamic exclusion of sequenced peptides was enabled for 40 s.
LOPIT-DC data processing. Raw data files were processed using Proteome Dis-
coverer v2.1 (Thermo Scientific). For the processing work flow, reporter ions were
scanned based on HCD activation, MS2 order, FTMS mass analyser with collision
energy between 0 and 1000. The peak integration method was set to the most
confident centroid with a 2 milli mass unit integration tolerance. Precursors were
selected based on MS1 with a precursor mass between 350 and 5000 Da and
minimum peak count of 1. Scan event filters were set to MS2 order, collision energy
between 0 and 1000, with full scan type. Peak Filters of S/N Threshold were set to
1.5. The Mascot server was searched against the Reviewed (Swiss-Prot) Human
Proteome (from UniProtKB at the UniProt database) with precursor and fragment
ion tolerances of ±20 ppm and ±0.2 Da, and up to two missed tryptic cleavages
permitted. Static modifications were set as carbamidomethylation of cysteine and
TMT 6-plex modification of lysine and peptide N termini. Dynamic modifications
were set as acetyl of the protein N-termini and oxidation of methionine. The PSMs
for the ‘forward’ and ‘decoy’ searches by Mascot were re-scored using the Perco-
lator algorithm to yield a more robust false discovery rate. For the consensus work
flow, protein grouping was enabled, with peptides used based on ‘Unique + Razor’.
Reporter quantification was based on an average reporter S/N of 5 and co-isolation
threshold of 30. No normalisation or scaling were applied. Quantifications were
hypothesis tested with ANOVA for individual proteins, a maximum fold change of
100, and the ratio was calculated using the summed abundance. Peptide group
modifications were set to a site probability threshold of 75. Peptides were validated
using the ‘automatic control peptide level rate if possible’ option using a strict and
relaxed target false discovery rates (FDR) of 0.01 and 0.05. Peptides were then
filtered for High FDR and master protein with a minimum peptide length of 5. No
imputation was performed. To improve signal-to-noise, proteins with a CRAPome
FREQ ≥ 0.1 (Supplementary Data 1)65, were filtered out prior to analysis unless
they were organelle markers use for SVM and TAGM classifications, along with
keratins, serum albumin and trypsin66. The data were then used to generate spatial
maps containing SVM and TAGM classifications using the Bioconductor v3.10
pRoloc work flow (see below)67. SVM classifications were set to an FDR of 0.05
based on the consensus from sub-cellular localisations obtained from the Human
Protein Atlas and Uniprot using the BioMart portal [https://www.ensembl.org/
info/data/biomart/index.html]68. All LOPIT-DC experiments were repeated three
times on separate days, with the treatments of each replicate performed con-
currently on the same day.
Posterior localisation probabilities. The posterior probability that a protein
belongs to a sub-cellular niche, henceforth referred to as the posterior localisation
probability, is computed using the TAGM-MAP method25. Briefly, the parameters
of the T-augmented Gaussian mixture model are learnt by maximising the log
posterior of the parameters with respect to the data, to obtain maximum a pos-
teriori (MAP) estimates of the parameters. The posterior localisation probability
that a protein belongs to each organelle is then computed and the most probable
sub-cellular niche is reported. Prior choices were made using the default settings in
the pRoloc work flow for the Bayesian analysis of spatial proteomics in the R (v3.6)
package Bioconductor (v3.10)67. Proteins predicted to localise to the mitochondria
and nucleus were discarded from subsequent analysis.
Bayesian non-parametric two-sample test. To detect perturbations in the quan-
titative protein profiles, we apply a Bayesian non-parametric two-sample test69. First,
the data are transformed using the additive log ratio transform70. We then proceed to
test whether the protein profiles are different between the control and treatment.
Formally, we test against two contrasting models. The first model posits that the
quantitative protein profiles in each experiment (control and treatment) are drawn
from an identical shared distribution. Whilst the second supposes that there are
independent models for each of the control and treatment. The log Bayes factor is
used to objectively determine support for one model over the other, where larger log
Bayes factors are considered support for the independent model71. A non-parametric
prior over functions, the Gaussian process, is specified with squared exponential
covariance72. Default Gamma priors were used for the hyperparameters of the
Gaussian process69. The natural logarithm of the Bayes factors is reported.
Mitochondrial ratios. To determine the biological relevance of quantitative pro-
tein profiles that are shifted between treatment and control, we computed a
mitochondrial ratio (MitoRatio) as follows. For each protein in each experiment,
the squared Mahalanobis distance73 to the mean of the quantitative profiles of the
mitochondrial marker proteins is computed, where a robust estimate for the
covariance is used74. Then, for each protein, the ratio of the distances in control
and treatment is computed, proceeded by a log2 transform. Proteins that move
closer to the mitochondria upon the treatment have larger mitochondrial ratios.
Reporting summary. Further information on research design is available in the Nature
Research Reporting Summary linked to this article.
Data availability
Mass spectrometry data used in this study are summarised in Supplementary Data files 1
and 2. All protein-level datasets generated during this study are available in the
Bioconductor pRolocdata package (version ≥ 1.25.2) at https://github.com/lgatto/
pRolocdata. Interactive versions of the PCA plots can be viewed online through dedicated
R Shiny apps at https://proteome.shinyapps.io/golgins_mito/, https://proteome.
shinyapps.io/golgins_golgin97mito/ and https://proteome.shinyapps.io/
golgins_gcc88mito/. The mass spectrometry proteomics data have been deposited to the
ProteomeXchange Consortium via the PRIDE75 partner repository with the dataset
identifier PXD018110. Protein localisation data from UniProt [https://www.uniprot.org/
help/subcellular_location] and the Human Protein Atlas [https://www.proteinatlas.org/]
were obtained using the BioMart portal [https://www.ensembl.org/info/data/biomart/
index.html]68. All reagents generated by this study are available from the corresponding
authors on request. Source data are provided with this paper.
Code availability
No custom code was used to generate, test or process the data described herein. Peptide
spectrum matching and quantification to protein-level abundances were performed in
Proteome Discoverer v2.1(Thermo Scientific) as described in the LOPIT-DC data
processing section. Protein localisation analyses were performed using the freely and
openly available R package Bioconductor (v3.10) using pRoloc as described in the
LOPIT-DC data processing section, and the Posterior localisation probabilities section
[http://bioconductor.org/packages/release/bioc/html/pRoloc.html]67.
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